CircIMMP2L promotes the malignant progression of ESCC mediated by CtBP1 nuclear retention, and is a robust biomarker for the diagnosis, prognosis, and LNM in ESCC. Here, CTBP1 is linked to esophageal squamous cell carcinoma.